Transcatheter Aortic Valve Replacement: Current Status and Future Indications

Manish Vinayak; Pier Pasquale Leone; Richard Tanner; Vishal Dhulipala; Anton Camaj; Rakhee Rajendra Kumar Makhija; Amit Hooda; Annapoorna S. Kini; Samin K. Sharma; Sahil Khera

doi:10.3390/jcm13020373

Transcatheter Aortic Valve Replacement: Current Status and Future Indications

Manish Vinayak, Pier Pasquale Leone, Richard Tanner, Vishal Dhulipala, Anton Camaj, Rakhee Rajendra Kumar Makhija, Amit Hooda, Annapoorna S. Kini, Samin K. Sharma, Sahil Khera

Research output: Contribution to journal › Review article › peer-review

11 Scopus citations

Abstract

In the past two decades, transcatheter aortic valve replacement (TAVR) has transformed the management of aortic stenosis and has become the standard of care regardless of surgical risk levels. Advances in transcatheter valve design across newer generations, improved imaging, greater operator expertise, and technical enhancements have collectively contributed to increased safety and a decline in procedural complications over this timeframe. The application of TAVR has progressively expanded to include younger patients with lower risks, who have longer life expectancies. This article offers an up-to-date review of the latest innovations in transcatheter delivery systems, devices, and its possible future indications.

Original language	English
Article number	373
Journal	Journal of Clinical Medicine
Volume	13
Issue number	2
DOIs	https://doi.org/10.3390/jcm13020373
State	Published - Jan 2024

Keywords

aortic stenosis
aortic valve replacement
transcatheter aortic valve replacement

Access to Document

10.3390/jcm13020373

Cite this

@article{8bec3eda55ae428da2bfb153ee1d6e7d,

title = "Transcatheter Aortic Valve Replacement: Current Status and Future Indications",

abstract = "In the past two decades, transcatheter aortic valve replacement (TAVR) has transformed the management of aortic stenosis and has become the standard of care regardless of surgical risk levels. Advances in transcatheter valve design across newer generations, improved imaging, greater operator expertise, and technical enhancements have collectively contributed to increased safety and a decline in procedural complications over this timeframe. The application of TAVR has progressively expanded to include younger patients with lower risks, who have longer life expectancies. This article offers an up-to-date review of the latest innovations in transcatheter delivery systems, devices, and its possible future indications.",

keywords = "aortic stenosis, aortic valve replacement, transcatheter aortic valve replacement",

author = "Manish Vinayak and Leone, {Pier Pasquale} and Richard Tanner and Vishal Dhulipala and Anton Camaj and Makhija, {Rakhee Rajendra Kumar} and Amit Hooda and Kini, {Annapoorna S.} and Sharma, {Samin K.} and Sahil Khera",

note = "Publisher Copyright: {\textcopyright} 2024 by the authors.",

year = "2024",

month = jan,

doi = "10.3390/jcm13020373",

language = "English",

volume = "13",

journal = "Journal of Clinical Medicine",

issn = "2077-0383",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "2",

}

TY - JOUR

T1 - Transcatheter Aortic Valve Replacement

T2 - Current Status and Future Indications

AU - Vinayak, Manish

AU - Leone, Pier Pasquale

AU - Tanner, Richard

AU - Dhulipala, Vishal

AU - Camaj, Anton

AU - Makhija, Rakhee Rajendra Kumar

AU - Hooda, Amit

AU - Kini, Annapoorna S.

AU - Sharma, Samin K.

AU - Khera, Sahil

PY - 2024/1

Y1 - 2024/1

N2 - In the past two decades, transcatheter aortic valve replacement (TAVR) has transformed the management of aortic stenosis and has become the standard of care regardless of surgical risk levels. Advances in transcatheter valve design across newer generations, improved imaging, greater operator expertise, and technical enhancements have collectively contributed to increased safety and a decline in procedural complications over this timeframe. The application of TAVR has progressively expanded to include younger patients with lower risks, who have longer life expectancies. This article offers an up-to-date review of the latest innovations in transcatheter delivery systems, devices, and its possible future indications.

AB - In the past two decades, transcatheter aortic valve replacement (TAVR) has transformed the management of aortic stenosis and has become the standard of care regardless of surgical risk levels. Advances in transcatheter valve design across newer generations, improved imaging, greater operator expertise, and technical enhancements have collectively contributed to increased safety and a decline in procedural complications over this timeframe. The application of TAVR has progressively expanded to include younger patients with lower risks, who have longer life expectancies. This article offers an up-to-date review of the latest innovations in transcatheter delivery systems, devices, and its possible future indications.

KW - aortic stenosis

KW - aortic valve replacement

KW - transcatheter aortic valve replacement

UR - http://www.scopus.com/inward/record.url?scp=85183376371&partnerID=8YFLogxK

U2 - 10.3390/jcm13020373

DO - 10.3390/jcm13020373

M3 - Review article

AN - SCOPUS:85183376371

SN - 2077-0383

VL - 13

JO - Journal of Clinical Medicine

JF - Journal of Clinical Medicine

IS - 2

M1 - 373

ER -

Transcatheter Aortic Valve Replacement: Current Status and Future Indications

Abstract

Keywords

Access to Document

Fingerprint

Cite this